基本信息
views: 83

Bio
Marc Pfister currently works at the Faculty of Medicine, University of Basel. Marc does pharmacology and pharmacometrics (PMX) Research with special interest in vulnerable populations such as children and patients with CKD. He is developing AI/ML/PMX based decision support tools to facilitate implementation of precision medicine with the ultimate goal to optimize and personalize treatment strategies in clinical practice.
Research Interests
Papers共 301 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Pharmaceuticsno. 5 (2025)
Frontiers in digital health (2025): 1497165-1497165
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYno. 1 (2025): 5-16
Anne Ravix,Verena Gotta,Marc Pfister,Christoph Berger, Antonia Glauser,Paolo Paioni,Chantal Csajka,Monia Guidi
JOURNAL OF CLINICAL PHARMACOLOGY (2025)
arxiv(2025)
Cited0Views0Bibtex
0
0
Klervi Golhen,Tatjana Welzel, Andrew Atkinson,Gilbert Koch, Dominic Braem, Johannes van den Anker,Andreas Woerner,Marc Pfister,Verena Gotta
Journal of clinical pharmacology (2025)
Marion Anliker-Ort,Frédérique Rodieux, Victoria Ziesenitz,Thomas O Erb,Stefan Holland-Cunz,Urs Duthaler,Deborah Rudin, John van den Anker,Marc Pfister,Verena Gotta
I) Posters (2024)
Schweizerische medizinische Wochenschriftno. 4 (2024): 3632-3632
David T. Ajayi, Ochuko M. Orherhe,Goonaseelan (Colin) Pillai, Samer Mouksassi,Britta Steffens,Dominic Bram, Viviane Sprecher,Daniela Hofmann,Michael Buettcher,Jean T. Coulibaly,Said M. Ali,Jennifer Keiser,Marc Pfister
JOURNAL OF CLINICAL PHARMACOLOGY (2024)
Load More
Author Statistics
#Papers: 301
#Citation: 5224
H-Index: 38
G-Index: 65
Sociability: 7
Diversity: 3
Activity: 40
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn